Literature DB >> 1658514

Beta- and alpha-adrenergic receptors are involved in regulating type II thyroxine 5'-deiodinase activity in the rat Harderian gland.

A Rubio1, J M Guerrero, M A Gonzalez, M A López-Gonzalez, C Osuna.   

Abstract

The role of alpha- and beta-adrenergic receptors in regulation of rat Harderian gland type II thyroxine 5'-deiodinase (5'-D) activity was investigated. Our results show that isoproterenol, a beta-adrenergic agonist, and phenylephrine, an alpha-adrenergic agonist, elicited increases in Harderian gland 5'-D activity. The activation was dependent on the time and the dose of the drug. Other adrenergic agonists, i.e., norepinephrine, methoxamine or terbutaline, also clearly increased the enzyme activity. Moreover, administration of propranolol, a beta-adrenergic blocker, or prazosin, an alpha-adrenergic blocker, completely prevented the activation of the enzyme induced by norepinephrine. Results show a clear regulation by adrenergic mechanisms of 5'-D activity in the rat Harderian gland, where alpha- and beta-adrenergic receptors appear to be involved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658514     DOI: 10.1016/0024-3205(91)90324-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Potentiating effect of phenylephrine on isoproterenol activation of thyroxine type II deiodinase in the pineal gland of adult rats.

Authors:  C Osuna; A Rubio; J M Guerrero
Journal:  Experientia       Date:  1993-04-15

2.  G-protein activation enhances Ca(2+)-dependent lipid secretion of the rat harderian gland.

Authors:  A P Gesase; Y Satoh; K Ono
Journal:  Anat Embryol (Berl)       Date:  1995-10

3.  Carbamylcholine-induced morphological changes and spatial dynamics of [Ca2+]c in Harderian glands of guinea pigs: calcium-dependent lipid secretion and contraction of myoepithelial cells.

Authors:  Y Satoh; Y Habara; T Kanno; K Ono
Journal:  Cell Tissue Res       Date:  1993-10       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.